A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1
This study is ongoing, but not recruiting participants.
Study NCT00267657
Information provided by National Institute on Drug Abuse (NIDA)
First Received: December 20, 2005
Last Updated: October 25, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
